TNBC expressed AR mRNA at a low level (p=.001) (Table 3), while high AR expression was observed in 66.7% of HR+HER2- BC, 80% of HR+HER2+ BC, and 71.4% of HR-HER2+ BC. Here, AR is linked to breast cancer.